# AndersonBrecon Inc. – FDA Inspection, Aug 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/65d9111f-80a9-46a6-a54e-d68b0eca8df8
Source feed: FDA_Inspections

> FDA inspection 1314012 of AndersonBrecon Inc., August 06, 2026. 1 citation under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314012
- Company Name: AndersonBrecon Inc.
- Inspection Date: 2026-08-06
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Chicago District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1295016 - 2026-08-19
- FDA Inspection 1173271 - 2022-06-10
- FDA Inspection 1106253 - 2019-09-04
- FDA Inspection 1077730 - 2018-12-05
- FDA Inspection 1008194 - 2017-03-23

## Related Officers

- [Investigator](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)

Company: https://www.keypedia.com/companies/andersonbrecon-inc/799f84ea-9114-456a-83f1-7edcd7eb4d2e

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669